Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin with NP Chemotherapy in Stage IIIA NSCLC
NCT02497118Phase 4Completed
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Aug 2010
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Started Aug 2010; status: completed.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02497118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497118.